Onyx Healthcare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Onyx Healthcare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare Services earnings growth | 29.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Here's How We Evaluate Onyx Healthcare Inc.'s (GTSM:6569) Dividend
Apr 14Returns On Capital At Onyx Healthcare (GTSM:6569) Paint A Concerning Picture
Mar 24Shareholders Of Onyx Healthcare (GTSM:6569) Must Be Happy With Their 46% Return
Mar 03Onyx Healthcare Inc.'s (GTSM:6569) Stock Been Rising: Are Strong Financials Guiding The Market?
Feb 05Should You Or Shouldn't You: A Dividend Analysis on Onyx Healthcare Inc. (GTSM:6569)
Jan 14Will Onyx Healthcare (GTSM:6569) Multiply In Value Going Forward?
Dec 23Did You Miss Onyx Healthcare's (GTSM:6569) 14% Share Price Gain?
Dec 02In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Onyx Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 1,293 | 182 | 107 | 114 | N/A |
6/30/2024 | 1,382 | 221 | 337 | 345 | N/A |
3/31/2024 | 1,440 | 250 | 366 | 417 | N/A |
12/31/2023 | 1,493 | 255 | 283 | 350 | N/A |
9/30/2023 | 1,545 | 264 | 210 | 281 | N/A |
6/30/2023 | 1,509 | 253 | 56 | 132 | N/A |
3/31/2023 | 1,509 | 217 | 145 | 176 | N/A |
12/31/2022 | 1,600 | 203 | 147 | 162 | N/A |
9/30/2022 | 1,542 | 202 | 205 | 215 | N/A |
6/30/2022 | 1,453 | 165 | 152 | 156 | N/A |
3/31/2022 | 1,348 | 152 | -242 | 23 | N/A |
12/31/2021 | 1,202 | 128 | -279 | 17 | N/A |
9/30/2021 | 1,207 | 122 | -192 | 108 | N/A |
6/30/2021 | 1,253 | 143 | -88 | 212 | N/A |
3/31/2021 | 1,368 | 182 | 227 | 271 | N/A |
12/31/2020 | 1,347 | 167 | 174 | 191 | N/A |
9/30/2020 | 1,274 | 148 | 35 | 53 | N/A |
6/30/2020 | 1,266 | 147 | 110 | 128 | N/A |
3/31/2020 | 1,352 | 188 | 181 | 195 | N/A |
12/31/2019 | 1,483 | 239 | 368 | 376 | N/A |
9/30/2019 | 1,521 | 207 | 319 | 326 | N/A |
6/30/2019 | 1,593 | 265 | 208 | 223 | N/A |
3/31/2019 | 1,474 | 241 | 240 | 259 | N/A |
12/31/2018 | 1,425 | 195 | 151 | 170 | N/A |
9/30/2018 | 1,366 | 212 | 214 | 228 | N/A |
6/30/2018 | 1,330 | 141 | N/A | 174 | N/A |
3/31/2018 | 1,343 | 106 | N/A | 161 | N/A |
12/31/2017 | 1,296 | 116 | N/A | 116 | N/A |
9/30/2017 | 1,280 | 154 | N/A | 207 | N/A |
6/30/2017 | 1,214 | 158 | N/A | 272 | N/A |
3/31/2017 | 1,160 | 159 | N/A | 148 | N/A |
12/31/2016 | 1,127 | 164 | N/A | 204 | N/A |
9/30/2016 | 1,054 | 120 | N/A | 167 | N/A |
6/30/2016 | 1,064 | 132 | N/A | 122 | N/A |
3/31/2016 | 1,013 | 126 | N/A | 154 | N/A |
12/31/2015 | 937 | 119 | N/A | 132 | N/A |
9/30/2015 | 884 | 115 | N/A | 83 | N/A |
6/30/2015 | 818 | 96 | N/A | 28 | N/A |
3/31/2015 | 768 | 81 | N/A | 67 | N/A |
12/31/2014 | 781 | 84 | N/A | 52 | N/A |
12/31/2013 | 660 | 44 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 6569's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if 6569's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 6569's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 6569's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 6569's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6569's Return on Equity is forecast to be high in 3 years time